Unlock Startup Cash: Your Ultimate Funding Formula

Raising capital for a growing business is one of the most important strategic decisions you'll make as a founder. Yet most scaling businesses approach fundraising reactively—cramming financials at the last minute, hoping investors will see the potential, and navigating term sheets with little preparation.

The reality is that fundraising is a process, not a single ask. It requires discipline, preparation, and a clear understanding of what investors actually care about. For scale-ups in the £1m–£100m revenue range, the stakes are higher than ever. You're competing for institutional capital alongside dozens of other growing companies, and your ability to tell a compelling financial and strategic story will determine whether you close funding or watch capital flow elsewhere.

This guide is built for founders, CEOs, and finance leads in UK scale-ups ready to raise growth capital. We've condensed the fundraising process into eight actionable steps, grounded in the experiences of Helm members who have raised tens of millions across tech, B2B, and deep tech companies.

The UK startup and scale-up ecosystem has matured significantly over the past five years. After a challenging 2022–2023, capital is returning, and institutional investors are actively backing proven teams with strong unit economics. For founders, this means more choices than ever—but also more complexity.

Venture capital remains the headline option, but VCs have shifted strategy. The £2m–£8m Series A is now the norm for tech companies with proven product-market fit and strong early revenue. Later-stage funding (Series B and beyond) increasingly flows to companies demonstrating unit economics and clear path to profitability.

Growth equity has become a major force, particularly for profitable or near-profitable scale-ups. Growth equity investors like BGF, Vitruvian, and Stride look for companies with £2m–£20m ARR and founders who've already demonstrated execution. Growth equity typically means larger cheques (£5m–£50m+) and lower dilution than VC.

Strategic investment and corporate VCs have doubled down on the UK market, particularly in fintech, biotech, and deeptech. If you're in a space where large acquirers or strategic partners exist, explore this route—it can move faster than VC and create optionality for exit.

Government and quasi-government schemes are underutilized by most founders. The British Business Bank, Regional Growth Fund, and local enterprise partnership grants can bridge capital gaps—and you can layer them with equity raises. Additionally, Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment Scheme (EIS) reliefs make it far easier to raise from angels at £500k–£2m stages.

For scale-ups with demonstrable R&D, tax credits remain an overlooked advantage. The R&D tax relief scheme can return 20–33% of qualifying spend, which can effectively subsidize your burn rate or accelerate growth investments without additional equity dilution.

Debt and venture debt have become strategic tools for profitable or near-profitable companies. Venture debt can buy 12–18 months of runway without dilution, allowing you to reach higher revenue milestones before Series B fundraising.

What this means for scale-ups: If you're in the £1m–£5m revenue range and haven't yet raised institutional capital, Series A VC is typically your path. If you're profitable or near-profitable at £5m+ revenue, growth equity unlocks larger cheques with lower founder dilution. If you're growing profitably, layering in venture debt or growth loans keeps equity dry for later stages.

Most founders underestimate how much diligence investors will conduct on your finances. A Series A investor won't just review your P&L; they'll audit revenue recognition, break down CAC by channel, model unit economics forward, and stress-test assumptions. Your goal is to make their job easy—and make it obvious that you understand your business deeply.

The core package: You need three years of historical financials (if available) and a detailed five-year forward projection. But projection quality varies wildly. Generic spreadsheets scream "I don't understand my business." Detailed, assumptions-driven models scream "I've thought through every variable."

The financial model itself should follow this structure: Assumptions → Historical Performance → Projections → Unit Economics Dashboard → Sensitivity Analysis.

The assumptions section is crucial. Investors spend 80% of their time here. If your assumption that "customer growth will increase 40% year-on-year" isn't backed by reasoning, it's dead on arrival. Instead, write: "We've acquired 150 customers organically over 18 months at an average CAC of £12k and LTV of £85k. To increase growth, we're adding two salespeople (cost £200k per annum each) targeting [specific segment]. Based on our current win rate (35%) and average deal size (£25k), we model 240 customer acquisitions in Year 1, scaling to 400 by Year 3."

Unit economics dashboards are your secret weapon. Create a one-page visual that shows: ARR, number of customers, CAC (by channel), LTV, LTV/CAC ratio, payback period, churn rate, and monthly recurring revenue (MRR) growth rate. Update this monthly and include it in every investor conversation. This signals that you're obsessed with metrics and understand what matters.

For UK companies, include a tax roadmap. Show how R&D credits, SEIS/EIS relief, patent box benefits, and other incentives reduce your true cost of expansion. A £3m Series A that qualifies for £300k in R&D credits is effectively a £2.7m raise. Savvy UK investors see this immediately; others need it explained.

Tax and compliance matter. Ensure you have: audited accounts (if turnover >£10m) or a clean tax return, HMRC confirmation of R&D eligibility, clear ownership structure (cap table), and no outstanding tax disputes. These are table stakes for Series A and beyond. Audit failures or tax surprises kill deals faster than any operational issue.

The best fundraising pitches don't feel like pitches. They feel like a founder explaining why they're obsessed with solving a specific problem for a specific customer, and how they've already started winning. The narrative does three things: it establishes credibility (you belong in this market), defines the opportunity (why now?), and proves traction (you're already winning).

Start with the insight. Not "we founded a fintech company." Instead: "Every founder we speak to spends 3–4 weeks per quarter managing compliance and invoicing. For a 50-person company, that's £250k in wasted salary. We've built software that automates this entirely." The insight should be specific enough that investors think "I know someone with that exact problem."

Then establish your unfair advantage. Why can you win where others fail? This isn't about being the smartest—it's about your specific positioning. Examples: "We have direct relationships with 500 procurement directors from our previous roles. Our competitors are cold-calling." Or: "We're the only founders in this space with 15 years of operations experience. Every feature we build directly solves a problem we've lived."

Make traction visceral. Don't just say "we have 100 customers." Say: "We have 100 customers in the insurance sector, who collectively represent £4bn in annual procurement spend. Our average customer saved £180k in their first year using our platform. That's led to 95% net retention and zero churn." Suddenly, the 100 customers feel like a foundation for something massive.

Address the elephant in the room early. If you're competing against a well-funded incumbent, don't ignore it. Acknowledge the competitor, then explain why you'll win: pricing, user experience, speed to market, or a specific customer segment they ignore. Founders who dodge this question signal weakness. Founders who engage with it honestly signal confidence.

The narrative structure in practice:

What kills narratives: Vague positioning ("we're a B2B SaaS company"), hand-wavy market sizing ("TAM is £100bn"), or founder humility disguised as weakness ("we're the underdogs"). Investors back conviction. Show it.

Due diligence typically happens after you've impressed an investor and they're considering a term sheet. But the smartest founders start preparing months earlier. This way, when an investor asks for your customer reference list, you're not scrambling—you're handing over a organized document with willing advocates.

Financial diligence. Investors will request: 36 months of P&L statements, balance sheets, and cash flow projections; proof of revenue (customer contracts, invoices, bank statements); documentation of any historical funding rounds; cap table and share register; details of any earn-outs or deferred compensation. You should have all of this organized, annotated, and ready to share within 48 hours. If you don't, you look unprepared.

Legal diligence. This is where founders often stumble. You'll need: articles of association and shareholder agreements; all historical employment contracts and offer letters; IP assignment agreements (confirming you own your tech, not your investors or employees); documentation of any patents filed (including filing dates); proof of data protection compliance (GDPR, privacy policies, data processing agreements); any material supplier or customer contracts. Missing or messy contracts destroy investor confidence.

Operational diligence. Investors will ask for: an org chart and bios of your top 10 staff; description of your product roadmap (next 18 months); customer reference list (5–10 customers representing your largest accounts and newest cohorts); detailed explanation of your top three customer wins (how you found them, what they paid, why they chose you); churn analysis (why customers leave, what you're doing about it); and competitive landscape analysis (top three competitors, why you'll win).

Create a data room. This is a shared, organized folder (Google Drive, Dropbox, or a proper data room tool like Intralinks) containing every document an investor might request. Organize it by category: Financial Documents, Legal Documents, Customer References, Product Roadmap, Market Analysis, Management Team. This signals organization and professionalism. Investors judge founders by their rigor, and a disorganized data room suggests disorganized operations.

Customer references matter enormously. Before you fundraise, secure 5–10 customer reference calls that investors can make. Brief these customers on what to expect, give them key metrics to share, and ensure they're your best advocates. A 20-minute call with a satisfied customer who's willing to advocate for you is worth 10 pages of market research. Investors will ask these customers: "What problem did they solve for you?" "What else did you consider?" "Would you recommend them?" Be prepared for these calls to happen.

For R&D tax credits: Document your R&D expenditure clearly. Keep payroll records showing who worked on R&D activities, save all project documentation, and get written confirmation from your accountant that your claim is legitimate. HMRC scrutinizes R&D claims, and a failed claim can cost you £300k–£1m. But a successful, documented claim is a material asset during fundraising.

Term sheets can feel overwhelming, but they have a predictable structure. The critical terms are: valuation (what the company is worth), investment amount (how much money you're raising), share class (what rights the new shares carry), board representation, liquidation preferences, and anti-dilution protection.

Valuation is the headline, but it's not everything. A £10m Series A at a £40m pre-money valuation feels great, but if the investor has strong anti-dilution protection or a higher liquidation preference, you might be better off with a £10m round at a £45m pre-money with lighter preferences. Valuation matters; terms matter more.

Board seats represent governance and optionality. Most Series A investors will take a board seat. This isn't inherently bad—good investors add real value. But negotiate: if they're taking a seat, does the CEO retain board control? Can you nominate a second founder seat? What about future investor seats? A board where the founder is outvoted is a risk.

Liquidation preferences determine who gets paid first in an exit. Standard preference is "1x non-participating"—investors get their money back first, then common shareholders (founders, employees) split the rest. Some investors push for "1x participating" (they get their money back AND participate in remaining proceeds). This is expensive for founders. Push back. 1x non-participating is fair.

Negotiate on founder-friendly terms: Single-trigger acceleration (options vest immediately on acquisition), single-trigger acceleration on acquisition by specific acquirers, or time-based acceleration (you vest faster after a certain period). Many founders miss this—it's worth thousands of pounds.

For multi-investor rounds: Ensure consistency. If one investor gets board representation, others may demand it too. If one investor gets a higher liquidation preference, others will demand parity. Work with your lawyer to structure the round so terms are aligned and governance is clear.

Hire a good lawyer. This is not the place to save £1k. A lawyer experienced with Series A/B financings in your sector will know what's standard, what to push back on, and what to concede. They'll save you multiples of their fee in negotiation.

Many founders treat the close of a fundraise as the finish line. In reality, it's the beginning of a multi-year partnership. The investors who add the most value are the ones with clear alignment, open communication, and shared expectations. You build this in the first 90 days.

First step: Clarify investor expectations. In your first board meeting, establish: What are the key milestones for the next 12 months? What does success look like? How frequently will you meet with your investors? Who's the primary contact? Will they introduce customers or partners? Will they expect weekly updates or monthly board packs? These conversations prevent surprise disappointments later.

Establish a rhythm. Monthly board calls (30–60 minutes), quarterly board meetings (full day, in person if possible), and annual strategy/planning sessions. Between meetings, send a monthly update: headline metrics (revenue, customer count, burn rate), what went well, what's challenging, and what you need from investors. This cadence builds trust and prevents surprises.

Monthly metrics dashboards matter. Create a one-page monthly update that shows: MRR/ARR, customer count, churn, CAC, LTV, runway, and headcount. Keep it consistent month-to-month so investors can see momentum or issues early. This isn't about impressing investors; it's about transparency and early problem-solving.

Use board meetings strategically. Don't spend time reviewing historical metrics (that's in the pack). Use board time for: strategic decisions (pricing, market expansion, M&A opportunities), hiring challenges (especially for difficult roles), capital planning (when will you need more money?), and customer wins/losses (why did that customer churn?). Board meetings are for decisions, not for updates.

For investor introductions: Many investors say they'll help with introductions. Take them up on this, but strategically. Identify 10–15 customers, partners, or channels you need access to. Ask your investors, one at a time, if they have connections. This works better than asking for a list of 50 names. And always close the loop—tell your investor what happened after the introduction.

Financial planning and forecasting cycles. By Q3 of your funding year, you should be thinking about your next fundraise (if needed). If you're profitable or on a clear path to profitability, you have optionality. If you're not, you need to start conversations 6–9 months before your runway becomes critical. Don't surprise your investors with a sudden Series B ask. Telegraph it early, and iterate on your plan with their feedback.

Protect your founder equity and focus. Post-investment, your job is building the business, not managing investors. Set boundaries around investor time. Yes, be transparent and responsive, but you need to protect the time and energy to operate your company. Investors who respect this are worth keeping. Investors who demand constant attention are costing you money.

Document decisions. Post each board meeting, send minutes: who attended, what was decided, who's accountable for what, and by when. This prevents the "I thought we agreed to X" conversation six months later. It also creates a paper trail that's useful if investor relationships ever become contentious.

Mistake #1: Pitching before you're ready. Many founders pitch to top-tier investors before they have traction. This burns your optionality. Top investors remember you and move on. Pitch when you have proof of traction: revenue, customer validation, or metrics that show real momentum. This typically means waiting until you have £500k+ ARR or 100+ customers.

Mistake #2: Taking the first term sheet. The first term sheet often isn't the best term sheet. It's just the first. Create competitive tension by taking meetings with 10–15 investors. When you have two serious offers, you have leverage to negotiate better terms. Most founders leave hundreds of thousands of pounds on the table by settling for the first offer.

Mistake #3: Misrepresenting traction. Inflating customer count, revenue, or growth rates destroys credibility. Investors will verify these numbers, and when they don't check out, the deal dies. Be honest about what you've achieved. Strong founders with real traction never need to exaggerate.

Mistake #4: Unclear use of proceeds. Investors want to know where their money is going. Don't say "we'll use this to grow the business." Instead: "We're hiring four salespeople (£300k), launching in three new geographies (£150k), and building the AI layer our customers are asking for (£200k)." Specificity signals confidence and planning.

Mistake #5: Founder conflict. If you have co-founders, get your story aligned before talking to investors. If they disagree on strategy, valuation, or vision, investors will notice and pull back. Co-founder alignment is a prerequisite for funding.

Mistake #6: Ignoring customer references. An investor will talk to your customers. If they say "the founders are brilliant but the product needs work" or "we're thinking about churning," the deal dies. Your customers are your best advocates. Make them successful first; ask them for introductions second.

Mistake #7: Burning bridges. You never know who'll become a future investor or board member. Be professional with every investor you talk to, even if they pass. The ones who pass today might lead your Series B if you're still growing in 18 months.

Mistake #8: Neglecting the details. Messy cap tables, unclear IP ownership, missing contracts, or tax disputes kill deals in the final weeks. Sort these things out before you start fundraising. It's cheaper to fix them proactively than to negotiate them under pressure.